Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer

The clinical decisions made when treating patients with metastatic cancer require knowledge of the current tumor extent and response to therapy. For the majority of solid tumors, a response assessment, which is based on imaging, is used to guide these decisions. However, measuring serum protein biom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: Hufnagl, Clemens, Leisch, Michael, Weiss, Lukas, Melchardt, Thomas, Moik, Martin, Asslaber, Daniela, Roland, Geisberger, Steininger, Philipp, Meissnitzer, Thomas, Neureiter, Daniel, Greil, Richard, Egle, Alexander
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2020
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956108/
https://ncbi.nlm.nih.gov/pubmed/31966080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11192
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge